Cargando…

Time in Range in Relation to All-Cause and Cardiovascular Mortality in Patients With Type 2 Diabetes: A Prospective Cohort Study

OBJECTIVE: There is growing evidence linking time in range (TIR), an emerging metric for assessing glycemic control, to diabetes-related outcomes. We aimed to investigate the association between TIR and mortality in patients with type 2 diabetes. RESEARCH DESIGN AND METHODS: A total of 6,225 adult p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lu, Jingyi, Wang, Chunfang, Shen, Yun, Chen, Lei, Zhang, Lei, Cai, Jinghao, Lu, Wei, Zhu, Wei, Hu, Gang, Xia, Tian, Zhou, Jian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Diabetes Association 2021
Materias:	Cardiovascular and Metabolic Risk
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9162101/ https://www.ncbi.nlm.nih.gov/pubmed/33097560 http://dx.doi.org/10.2337/dc20-1862

Ejemplares similares

Metabolic Syndrome and All-Cause and Cardiovascular Mortality in an Italian Elderly Population: The Progetto Veneto Anziani (Pro.V.A.) Study
por: Zambon, Sabina, et al.
Publicado: (2009)

Casual blood glucose and subsequent cardiovascular disease and all-cause mortality among 159 731 participants in Cohort of Norway (CONOR)
por: Riise, Hilde Kristin Refvik, et al.
Publicado: (2021)

Renal hyperfiltration is independently associated with increased all-cause mortality in individuals with type 2 diabetes: a prospective cohort study
por: Penno, Giuseppe, et al.
Publicado: (2020)

Heart Rate–Corrected QT Interval Is an Independent Predictor of All-Cause and Cardiovascular Mortality in Individuals With Type 2 Diabetes: The Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

Cardiovascular and All-Cause Mortality Over a 23-Year Period Among Chinese With Newly Diagnosed Diabetes in the Da Qing IGT and Diabetes Study
por: An, Yali, et al.
Publicado: (2015)

All-Cause and Specific-Cause Mortality Risk After Roux-en-Y Gastric Bypass in Patients With and Without Diabetes
por: Lent, Michelle R., et al.
Publicado: (2017)

Development of a predictive risk model for all-cause mortality in patients with diabetes in Hong Kong
por: Lee, Sharen, et al.
Publicado: (2021)

The association of comorbid diabetes mellitus and symptoms of depression with all-cause mortality and cardiac rehospitalization in patients with heart failure
por: Reeves, Geri C, et al.
Publicado: (2015)

Adapted Diabetes Complications Severity Index and Charlson Comorbidity Index in predicting all-cause and cause-specific mortality among patients with type 2 diabetes
por: Hu, Yu-Wen, et al.
Publicado: (2023)

Long-term variability of glycemic markers and risk of all-cause mortality in type 2 diabetes: the Look AHEAD study
por: Kaze, Arnaud D, et al.
Publicado: (2020)

Genetic Risk Score Associations With Cardiovascular Disease and Mortality in the Diabetes Heart Study
por: Cox, Amanda J., et al.
Publicado: (2014)

Associations of Type 2 Diabetes Onset Age With Cardiovascular Disease and Mortality: The Kailuan Study
por: Zhao, Maoxiang, et al.
Publicado: (2021)

Association Between Insulin Resistance and Cardiovascular Disease Risk Varies According to Glucose Tolerance Status: A Nationwide Prospective Cohort Study
por: Wang, Tiange, et al.
Publicado: (2022)

Association between varying cut-points of intermediate hyperglycemia and risk of mortality, cardiovascular events and chronic kidney disease: a systematic review and meta-analysis
por: Gujral, Unjali P, et al.
Publicado: (2021)

Impact of type 2 diabetes and microvascular complications on mortality and cardiovascular outcomes in a multiethnic Asian population
por: Yap, Jonathan, et al.
Publicado: (2021)

Cardiac autonomic neuropathy and risk of cardiovascular disease and mortality in type 1 and type 2 diabetes: a meta-analysis
por: Chowdhury, Mahin, et al.
Publicado: (2021)

ASCVD risk stratification modifies the effect of HbA1c on cardiovascular events among patients with type 2 diabetes mellitus with basic to moderate risk
por: Zhang, Hongmei, et al.
Publicado: (2020)

Association of HbA1c With All-cause Mortality Across Varying Degrees of Glycemic Variability in Type 2 Diabetes
por: Lu, Jingyi, et al.
Publicado: (2021)

Impact of the Complexity of Glucose Time Series on All-Cause Mortality in Patients With Type 2 Diabetes
por: Cai, Jinghao, et al.
Publicado: (2022)

Risk of cardiovascular event and mortality in relation to refill and guideline adherence to lipid-lowering medications among patients with type 2 diabetes mellitus in Sweden
por: Karlsson, Sofia Axia, et al.
Publicado: (2019)

Contrasting Associations Between Diabetes and Cardiovascular Mortality Rates in Low-, Middle-, and High-Income Countries: Cohort Study Data From 143,567 Individuals in 21 Countries in the PURE Study
por: Anjana, Ranjit Mohan, et al.
Publicado: (2020)

Pioglitazone and cause-specific risk of mortality in patients with type 2 diabetes: extended analysis from a European multidatabase cohort study
por: Strongman, Helen, et al.
Publicado: (2018)

Diabetes with poor-control HbA1c is cardiovascular disease ‘risk equivalent’ for mortality: UK Biobank and Hong Kong population-based cohort study
por: Wan, Eric Yuk Fai, et al.
Publicado: (2023)

Lipid-lowering treatment patterns among patients with type 2 diabetes mellitus with high cardiovascular disease risk
por: Quek, Ruben G W, et al.
Publicado: (2015)

Characteristics Associated With Decreased or Increased Mortality Risk From Glycemic Therapy Among Patients With Type 2 Diabetes and High Cardiovascular Risk: Machine Learning Analysis of the ACCORD Trial
por: Basu, Sanjay, et al.
Publicado: (2018)

Hispanic representation in diabetes cardiovascular outcomes trials
por: Kelley, A. Taylor, et al.
Publicado: (2019)

Diabetes and infectious disease mortality in Mexico City
por: Bragg, Fiona, et al.
Publicado: (2023)

Birth weight modifies the relation between adulthood levels of insulin-like growth factor-1 and type 2 diabetes: a prospective cohort study
por: Geng, Tingting, et al.
Publicado: (2021)

Glycemic variability and cardiovascular disease in patients with type 2 diabetes
por: Martinez, Marcela, et al.
Publicado: (2021)

Influence of age on the prevalence and components of the metabolic syndrome and the association with cardiovascular disease
por: Devers, Marion C, et al.
Publicado: (2016)

Cardiovascular Determinants of Aerobic Exercise Capacity in Adults With Type 2 Diabetes
por: Gulsin, Gaurav S., et al.
Publicado: (2020)

Cardiovascular Risk Reduction With Liraglutide: An Exploratory Mediation Analysis of the LEADER Trial
por: Buse, John B., et al.
Publicado: (2020)

Impact of Brazil’s Bolsa Família Programme on cardiovascular and all-cause mortality: a natural experiment study using the 100 Million Brazilian Cohort
por: Pescarini, Julia M, et al.
Publicado: (2022)

Increased Risk of Cardiovascular Disease in Young Women Following Gestational Diabetes Mellitus
por: Shah, Baiju R., et al.
Publicado: (2008)

Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India
por: Gupta, Arvind, et al.
Publicado: (2014)

Effects of Severe Hypoglycemia on Cardiovascular Outcomes and Death in the Veterans Affairs Diabetes Trial
por: Davis, Stephen N., et al.
Publicado: (2019)

Diabetic retinopathy as an independent predictor of subclinical cardiovascular disease: baseline results of the PRECISED study
por: Simó, Rafael, et al.
Publicado: (2019)

Effects of BMI and LDL-cholesterol change pattern on cardiovascular disease in normal adults and diabetics
por: Youk, Tae Mi, et al.
Publicado: (2020)

Cardiovascular risk management in people with type 1 diabetes: performance using three guidelines
por: Varkevisser, Rita Delphine Maiko, et al.
Publicado: (2022)

Immunoglobulin G N-Glycosylation Signatures in Incident Type 2 Diabetes and Cardiovascular Disease
por: Birukov, Anna, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_hi6heiplo4aj6al163h46cvdsk